بدائل البحث:
significantly improve » significantly improved (توسيع البحث)
improve decrease » improve disease (توسيع البحث), improved urease (توسيع البحث), improves disease (توسيع البحث)
sizes decrease » scores decreased (توسيع البحث), rivers decreased (توسيع البحث)
gap decrease » a decrease (توسيع البحث), gain decreased (توسيع البحث), mean decrease (توسيع البحث)
significantly improve » significantly improved (توسيع البحث)
improve decrease » improve disease (توسيع البحث), improved urease (توسيع البحث), improves disease (توسيع البحث)
sizes decrease » scores decreased (توسيع البحث), rivers decreased (توسيع البحث)
gap decrease » a decrease (توسيع البحث), gain decreased (توسيع البحث), mean decrease (توسيع البحث)
-
1
-
2
Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
3
Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
4
Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
5
Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
6
Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
7
Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
8
Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
9
Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx
منشور في 2025"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
-
10
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
منشور في 2025"…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"
-
11
Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023.
منشور في 2025الموضوعات: -
12
Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023.
منشور في 2025الموضوعات: -
13
-
14
-
15
-
16
-
17
Transition probabilities and class sizes for three-step LTA model (N = 432).
منشور في 2025الموضوعات: -
18
-
19
-
20